Links with industry
As a translational research Institute NICR works particularly closely with commerce in the pharmaceutical and biotech sectors on:
Pre-clinical drug discovery
NICR has had major pre-clinical drug discovery collaborations with:
- Pfizer GRD (San Diego, USA )
- Astex Therapeutics (Cambridge)
- AstraZeneca Pharmaceuticals (Manchester)
- Cancer Research Technology (London)
- Sienna Biotech (Sienna, Italy)
Clinical trials research
This involves collaboration with companies to investigate the utility of novel anticancer agents, and NICR has recently worked with:
- Adult solid tumour studies - Antisoma, Astex, AstraZeneca, Bayer, Biogen Idec, BiPar, BMS, Boehringer Ingelheim, CellCentric, CTI, Eli Lilly, GSK, Human Genome Sciences, MGI, Nanocarrier, Nerviano, Novartis, Onopharma, OSI, Pharmamar, Pfizer, Pierre Fabre, Roche, Sanofi-Aventis, Schering Plough, Telik, Theradex, Vernalis
- Adult haematological malignancies – Amgen, Baxter, Bioenvision, BMS, Chugai, Novartis, Seattle Genetics, Schering, Roche.
